New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
08:06 EDTRTRXRetrophin completes acquisition of Manchester Pharmaceuticals
Retrophin announced the completion of the previously announced acquisition of Manchester Pharmaceuticals LLC for a total of $62.5M, including an upfront payment of $29.5M, plus other payments based on product sales. Retrophin intends to pursue U.S. regulatory approval for Chenodal in cerebrotendinous xanthomatosis.
News For RTRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 14, 2014
08:01 EDTRTRXRetrophin divests non-core assets to Turing Pharmaceuticals
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use